Twist Bioscience Corp (TWST) stock
TWSTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 13/30237% above fair value
$111.60−2.62 (-2.29%)
Close on Nov 13, 2026Market cap $7.00BP/E –Yield –
Twist Bioscience enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Twist Bioscience's enterprise value was $7.52B on Nov 11, 2026, against $1.71B a year earlier. Over the last 5 years it ranged from $268.22M to $11.94B, with a median of $1.88B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $7.52B | +344.5% |
| 2025 | Dec 31, 2025 | $1.69B | -31.2% |
| 2024 | Dec 31, 2024 | $2.46B | +37.6% |
| 2023 | Dec 29, 2023 | $1.79B | +112.3% |
| 2022 | Dec 30, 2022 | $840.84M | -74.9% |
| 2021 | Dec 31, 2021 | $3.35B | -44.9% |
| 2020 | Dec 31, 2020 | $6.08B | +986.6% |
| 2019 | Dec 31, 2019 | $559.96M | +18636.2% |
| 2018 | Dec 31, 2018 | $2.99M | – |
See a number that looks wrong?